539206 logo

Genomic Valley Biotech BSE:539206 Stock Report

Last Price

₹82.20

Market Cap

₹251.1m

7D

-11.9%

1Y

162.7%

Updated

22 Dec, 2024

Data

Company Financials

Genomic Valley Biotech Limited

BSE:539206 Stock Report

Market Cap: ₹251.1m

539206 Stock Overview

Operates in horticulture business activities in India. More details

539206 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Genomic Valley Biotech Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Genomic Valley Biotech
Historical stock prices
Current Share Price₹82.20
52 Week High₹108.15
52 Week Low₹28.36
Beta0.39
1 Month Change-16.42%
3 Month Change0.74%
1 Year Change162.70%
3 Year Changen/a
5 Year Changen/a
Change since IPO896.36%

Recent News & Updates

Recent updates

Shareholder Returns

539206IN Professional ServicesIN Market
7D-11.9%-3.3%-4.2%
1Y162.7%28.8%19.1%

Return vs Industry: 539206 exceeded the Indian Professional Services industry which returned 28.8% over the past year.

Return vs Market: 539206 exceeded the Indian Market which returned 19.1% over the past year.

Price Volatility

Is 539206's price volatile compared to industry and market?
539206 volatility
539206 Average Weekly Movement4.5%
Professional Services Industry Average Movement6.3%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 539206 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 539206's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19943Yogesh Agrawalwww.genomicvalley.com

Genomic Valley Biotech Limited operates in horticulture business activities in India. The company involved in the commercial greenhouse/poly house cultivation of crops; commercial horticulture activities with aloe vera, tomato, bitter gourd, bottle gourd, brinjal, broccoli, cabbage, capsicum, carrot, cauliflower, cucumber, green chilies, onion, radish, ridge/sponge gourd, leafy vegetables, pumpkin, banana, guava, papaya, and strawberry; and commercial floriculture of flowers. It undertakes contracts for its clients for erecting greenhouses; and provides turnkey consultancy services.

Genomic Valley Biotech Limited Fundamentals Summary

How do Genomic Valley Biotech's earnings and revenue compare to its market cap?
539206 fundamental statistics
Market cap₹251.08m
Earnings (TTM)₹2.40m
Revenue (TTM)₹3.99m

104.5x

P/E Ratio

62.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
539206 income statement (TTM)
Revenue₹3.99m
Cost of Revenue₹0
Gross Profit₹3.99m
Other Expenses₹1.59m
Earnings₹2.40m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.79
Gross Margin100.00%
Net Profit Margin60.18%
Debt/Equity Ratio0%

How did 539206 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:53
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genomic Valley Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution